PARTNERS & CORPORATE MEMBERS

MCKESSON SPECIALTY HEALTH

At McKesson Specialty Health, we have a vision – that the long term vibrancy of community care will be achieved through the leadership of physicians committed to clinical excellence and innovation, enabled by close collaboration with our organization and our deep clinical, operational and technological expertise.

We offer solutions that provide practices with the choice, flexibility and ability to engage with us through a variety of innovative clinical, technology, business, and practice management capabilities. Read more.

MCKESSON MED-SURG

With the pressures of today’s healthcare environment, it’s important to have an ally that can help you stay focused on providing quality care. At McKesson Medical-Surgical, we work to understand your daily challenges so that, together, we can develop a plan to address your business needs. We offer more products, distribution services, solutions and clinical support to healthcare providers than other medical supply distributors. Read more.

AVYXA

AVYXA is a specialty pharmaceutical company that is focused on the development and marketing of complex therapies that make a difference for cancer patients, providers and the healthcare system. Our core values are grounded in providing access to meaningful products that improve patient care. Read more.

CELLTRION

Celltrion USA is Celltrion Healthcare’s U.S. subsidiary established in 2018. Headquartered in New Jersey, Celltrion USA is committed to expanding access to innovative biologics to improve care for U.S. patients. Celltrion currently has five biosimilars approved by the U.S. FDA: Inflectra® (infliximab-dyyb), Truxima® (rituximab-abbs), Herzuma® (trastuzumab-pkrb), Vegzelma® (bevacizumab-adcd), and Yuflyma®(adalimumab-aaty). Celltrion USA will continue to leverage Celltrion Healthcare’s unique heritage in biotechnology, supply chain excellence, and best-in-class sales capabilities to improve access to high-quality biopharmaceuticals for U.S. patients.  Read more.

MERCK

At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types. Read more.

NAVISTA

Navista empowers community oncology practices to deliver personalized, patient -centered cancer care close to home. Through advanced services, technology, and financial support, they help practices stay independent while reducing administrative burdens and preserving physician autonomy across a nationwide network. Read more.

PHARMACOSMOS THERAPEUTICS

Pharmacosmos Therapeutics Inc. is a U.S. specialty pharmaceutical company dedicated to providing patient care through the commercialization of Monoferric^® (ferric derisomaltose) injection and through exceptional resources to support this treatment. We are the U.S. affiliate of the Denmark-based Pharmacosmos Group. Please visit our website to learn more.

REGENERON

Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly translate science into medicine has led to numerous FDA-approved treatments and candidates in development. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, and through research initiatives such as the Regeneron Genetics Center.  Read more.

AMNEAL

At Amneal, we believe in reducing barriers to patients accessing the medicines they need most. That’s why we are committed to ensuring access to quality therapies. Amneal is committed to building and maintaining a meaningful presence in the oncology space with biosimilars and evolved formulations of buy-and-bill oncology therapies. Read more.

ASSERTIO

We are a leading commercial pharmaceutical company bringing differentiated products to patients. We have a robust portfolio of branded prescription neurology, inflammation, pain and oncology medications.  Read more.

INFUSYSTEM

InfuSystem is a leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Texas, Georgia and Ontario, Canada. The Company’s stock is traded on the NYSE American under the symbol INFU. Read more.

OCTAPHARMA